$CLNN 3/A SEC Filings

Filed On	Filing
21 Jul 2021	Form 3/A: Mosca Alison, Director
21 Jul 2021	Form 3/A: Matlin David J, Director
14 Apr 2021	Form 3/A: Wilcox Reed N, Director
13 Apr 2021	Form 3/A: Jacobovitz Shalom, Director
13 Apr 2021	Form 3/A: Glanzman Robert, Chief Medical Officer
13 Apr 2021	Form 3/A: Mortenson Mark, Chief Science Officer
13 Apr 2021	Form 3/A: Etherington Robert Dee, Director
13 Apr 2021	Form 3/A: Mosca Alison, Director
13 Apr 2021	Form 3/A: Stevens John Henry, Director
22 Jan 2021	Form 3/A: Mosca Alison, Director Holds 32,393 shares of Common Stock
22 Jan 2021	Form 3/A: Matlin David J, Director Holds 1,171,213 shares of Common Stock
07 Jan 2021	Form 3/A: Etherington Robert Dee, Director Holds 12,717 shares of Common Stock

Comments